CRE Office Vacancy Hits 24%: The Refinancing Crisis and Conversion Opportunity in 2026

# CRE Office Vacancy Hits 24%: The Refinancing Crisis and Conversion Opportunity in 2026

> **Quick answer:** U.S. commercial real estate office vacancy has reached approximately 24% in 2026 — the highest level ever recorded — as $936 billion in CRE loans mature into a rate environment that makes refinancing mathematically impossible for most owners. Over half of maturing CMBS office loans are expected to default. Yet the same crisis is generating the most compelling distressed-asset opportunity in office real estate since 2009: cities with 20%+ vacancy are actively incentivizing office-to-residential conversions, 90,300 apartment units are already in the conversion pipeline (nearly four times the 2022 figure), and distressed properties are trading at 50-80 cents on the dollar in markets where housing demand is acute.

*This article is for informational purposes only and does not constitute financial or investment advice. Consult a qualified financial advisor before making real estate investment decisions.*

Commercial real estate office vacancy at 24 percent in 2026 represents a number without modern precedent in U.S. property history — but the story underneath that headline is not simply one of decline. It is a story of two simultaneously operating markets: a crisis for owners carrying debt originated at 2017-2019 values, and an opportunity for buyers who can move on distressed assets without legacy financing constraints. Understanding which side of that divide you stand on is the most important CRE analysis question of 2026.

## Why Office Vacancy Hit 24%: The Structural Shift No Recovery Cycle Can Fix

The commercial real estate office vacancy crisis did not happen because of a recession. It happened because remote and hybrid work permanently retired demand for roughly 30% of existing U.S. office stock — a shift that McKinsey Global Institute quantified in its 2023 research, finding global office usage had stabilized 30% below pre-pandemic baselines with no evidence of reversal.